Don L. Gibbons

发表

Deep learning-based prediction of the T cell receptor–antigen binding specificity

John V. Heymach, Yunguan Wang, Tao Wang, 2021, Nature Machine Intelligence.

Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches

Boris Sepesi, Ignacio I. Wistuba, John V. Heymach, 2018, Journal of Immunotherapy for Cancer.

Map2k4 Functions as a Tumor Suppressor in Lung Adenocarcinoma and Inhibits Tumor Cell Invasion by Decreasing Peroxisome Proliferator-Activated Receptor γ2 Expression

Yanan Yang, Young-Ho Ahn, Elizabeth J. Goldsmith, 2011, Molecular and Cellular Biology.

A genetic cell context-dependent role for ZEB1 in lung cancer

Zhifu Sun, Yanan Yang, Ping Yang, 2016, Nature Communications.

Multiplatform-based Molecular Subtypes of Non-Small Cell Lung Cancer

Yiling Lu, Rehan Akbani, Gordon B. Mills, 2016, Oncogene.

Expression Signatures of Metastatic Capacity in a Genetic Mouse Model of Lung Adenocarcinoma

Dror Berel, Yanan Yang, Ignacio I. Wistuba, 2009, PloS one.

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

Ying Feng, Pan Tong, Robert J. Cardnell, 2017, Oncotarget.

TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins

Chad J. Creighton, Don L. Gibbons, C. Creighton, 2018, Nature Communications.

Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients

Jaime Rodriguez-Canales, Humam Kadara, Boris Sepesi, 2016, Clinical Cancer Research.

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumor cell PD-L1 expression and intratumoral immunosuppression

Lixia Diao, F. Xiao-Feng Qin, Gordon Robertson, 2014, Nature Communications.

A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition

Jaime Rodriguez-Canales, Pan Tong, Kevin R. Coombes, 2015, Clinical Cancer Research.